Company

RETHINK WELLNESS
Company presentation
March 2017

DISCLAIMER
This communication does not constitute an offer to purchase or exchange or the solicitation of an offer to sell or exchange any securities of the Company.
This communication contains certain statements that are neither reported financial results nor other historical information and other statements concerning the Company.
These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations,
events, products and services and future performance. Forward-looking statements are generally identified by the words “will”, "expects", "anticipates", "believes", "intends", "estimates“, “target”,
and similar expressions. These and other information and statements contained in this communication constitute forward-looking statements for purposes of applicable securities laws.
Although management of the Company believes that the expectations reflected in the forward looking statements are reasonable, investors and security holders are cautioned that forwardlooking
information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of the Company, that could cause
actual results and developments to differ materially from those expressed in, or implied or projected by the forward-looking information and statements, and the Company cannot guarantee
future results, levels of activity, performance or achievements.
Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in
target markets; the Company's ability to develop new technology and products; effects of competition in the Company's main markets; challenges to or loss of intellectual property rights;
ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and
regulatory forces. Moreover, neither the Company nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. The forward-looking
statements contained in this communication speak only as of the date of this communication and the Company or its representatives are under no duty, and do not undertake, to update any
of the forward-looking statements after this date to conform such statements to actual results, to reflect the occurrence of anticipated results or otherwise except as otherwise required by
applicable law or regulations
OTCQB:TECR

WHO WE ARE
TechCare is a technology company engaged in the design,
development and commercialization of an innovative platform
utilizing the vaporization of various natural, plant-based
compounds, to enable a wide variety of treatment solutions.
OTCQB:TECR

OUR VISION
TechCare aims to improve quality of life
by leveraging innovative technology, to
develop valuable products that deliver
an optimal customer experience.
OTCQB:TECR

INNOVATIVE SOLUTIONS
Novokid
Ready for market 2017
head lice
treatment
De-Bug
treatment
for household
pests
Shine
hair
rejuvenation
Future products in development
Dermatology
Applications
OTCQB:TECR

WHAT IS OUR USP ?
Vapor Capsule Dry Natural,
plant-based
OTCQB:TECR

THE MARKET OPPORTUNITY
HEAD LICE
NOVOKID - Head Lice Treatment
Global head lice treatment market
$1.8 billion
HAIR CARE
SHINE - Hair Rejuvenation
Global market for haircare products
$83.1 billion
6-12 million children get head lice each year in the US alone
12-24 million school days are lost by students, in the US costing $1 billion annually
BED BUGS
Treatment for Household Pests
Global market for human insect
and parasite treatment
$2.5 billion
DERMATOLOGY APPLICATION
Global market
for dermatology products
$8.22 billion
OTCQB:TECR

Introducing
NOVOKID
OTCQB:TECR

CURRENT TREATMENT OPTIONS
Treatment Resistant Lice
• Purple 100%
• Green 50%-90
• Yellow 1-49%
98% of lice have
developed resistance
to existing treatments
in the US
Most treatments contain,
pesticides, alcohol or
silicone which are associated
with a wide variety of
hazardous side effects.
Most treatments
are expensive and
time-consuming
Most existing treatments
are burdensome and
inconvenient for both
children and parents.
OTCQB:TECR

NOVOKID
- INNOVATIVE LICE TREATMENT DEVICE
Proven as an effective and
sustainable treatment against
head lice and super lice.
An innovative and proprietary
solution, developed through
years of research carried
out by renowned scientists.
Extremely user-friendly.
Does not require standard
post-treatment steps such
as shampooing or rinsing.
Effective as a
preventative treatment
if used on an ongoing
basis.
OTCQB:TECR

NOVOKID
HOW IT WORKS
1
2
Place hair
inside cap
Connect cap
to capsule
3
4
Turn on the device
and have fun for 10min!
Remove cap
and capsule
OTCQB:TECR

NOVOKID
outperforming the competition
Chemical Natural Novokid
Kills Lice Unproven Unproven Kills lice
Kills Eggs Unproven Unproven Treats eggs
Kills Super Lice Unproven Unproven Kills super lice
Time required 20-40 mins 20-40 mins 10 mins
Shampooing Required Required Not required. Dry treatment
Combing Required Required Recommended
Compound Chemical Not FDA approved Natural, plant-based, Eco-friendly
NOVOKID : efficient, quick, safe and easy
OTCQB:TECR

OTCQB:TECR
NOVOKID

y
Introducing
OTCQB:TECR

evolutionary haircare rejuvenation
Adds natural
body and shine
Cleans hair and
scalp
Defines curls
Treats split ends
and breakage
Balances pH
level
Anti-bacterial
and anti-fungal
properties
OTCQB:TECR

y
MAIN FEATURES
A natural, plant-based
solution, with no added
chemicals.
Proven as an effective and
sustainable treatment for
healthy, lustrous and
manageable hair.
Extremely user-friendly -
does not require
standard steps such as
shampooing or rinsing.
OTCQB:TECR

HOW IT WORKS
1
2
Insert capsule
into device
Cover all hair
with the cap
1
3 4
Turn on device and
have fun for 10 mins!
Remove cap
and capsule
4
OTCQB:TECR

OTCQB:TECR
FUTURE PRODUCTS

DEVELOPMENT PIPELINE
We are constantly working to develop new products,
applying our innovative proprietary technology to a broad range of everyday issues,
from household fumigation to dermatological treatments.
BED BUGS
Household pests
A unique and proprietary
solution for the effective and
eco-friendly treatment of bed
bugs and household pests.
Applicable to clothes, linen
and mattresses.
DERMATOLOGY
APPLICATION
We are currently exploring
the effectiveness of
vaporized solutions to
effectively treat a wide
range of skin conditions.
OTCQB:TECR

COMPANY MILESTONES
Awarded
ISO 9001
Certification
<
Product Launch
(Israel, Europe)
- Novokid
<
POC – De Bug
<
Awarded
Medical
Equipment
Approval - Israeli
Ministry of Health
- Novokid
Granted
European
Patent
<
<
Awarded CE Approval
Medical Device - Novokid
Commencement
of Trading
(OTCQB – TECR)
Granted
US Patent
<
<
<
Product Launch
(Israel, Europe)
- Shine
`CE Cosmetics
Approval
- Shine FDA
Approval
Cosmetics
- Shine
Q4
Q2
<
<
Q3
<
<
<
<
Product
Launch (US)
- Shine
Product
Launch (US)
- Novokid
FDA
Approval
- Novokid
Q3
<
<
<
<
<
POC –
Dermatology
Applications
Q1
<
<
Q4
2015 2016 2017 2018
OTCQB:TECR

OUR LEADERSHIP
Zvi Yemini
Chairman - CEO
Zvi has over 35 years of experience in the
plastics industry, both in management and
as an investor. A serial entrepreneur, he
founded leading companies such as: ZAG
Industries (sold to Stanley Black & Decker),
Polymer Logistics and Hydro Industries. He
currently serves as Chairman of Shenkar
College of Design.
Shlomi Arbel
COO
With over 10 years of experience in
various leadership roles in Israeli and
multi-national corporations. He also
serves as a board member of several
corporations engaged in the fields of
telecom, IOT and medical devices.
Josh Johnson
CFO
Josh has over 10 years of
professional accounting experience
with established companies and
start-ups in various fields, including
medical devices, telecom and
gaming. He also has vast
experience in publicly traded
companies listed on NASDAQ,
AIM, FTSE and TASE.
Vered Zur
VP Marketing
Yehuda Einav
VP R&D
Hagit Cohen
Operations Manager
Over 15 years of experience leading the
marketing activities for local and global
companies in the fields of telecom,
consumer goods and software. Vered
expertise includes working in both B2B
& B2C environments.
Yehuda has more than 25 years of
experience in R&D, product design and
manufacturing, with specific expertise in
plastic based consumer products. He
previously served as R&D manager at Zag
Industries and Stanley Black & Decker.
Hagit comes with over 10
years of experience as product
and operation manager in
leading multi-national
companies such as Ketter, Star
Plast and Polymer Logistics.
OTCQB:TECR

SCIENTIFIC ADVISORY BOARD
NAVA RAVID
DR. URI STOIN
DR. MICHAEL SAMISH
PROF. FERNANDO
PATOLSKY
Former CEO, L’Oréal Israel,
owner and CEO of Skin Test
Center. A skin-care industry
expert, with over 30 years of
experience in management,
marketing, manufacturing,
branding and strategy.
Responsible for launching new
products and new product
categories for some of the
world’s largest brands.
PhD in Applied Chemistry.
Holds positions at the
Hebrew University of
Jerusalem and several
corporations in Israel and
Switzerland. Dr Stoin has
published several papers and
articles and has 11 registered
patents to his name.
PhD from the Faculty of
Medicine at Tel Aviv University,
with a focus of Entomology.
Previously held positions at the
Hebrew Uni versi ty of
Jerusalem, US Department of
Agri cu l tu re and Rutgers
University. Member of the
Israeli Entomological Society.
PhD in Chemistry. Head of the
Patolsky Center for Nano
Science and Nano Technology
at Tel Aviv University. Winner of
the Schmidt Prize (2005); the
Alon Fellowship Award (2006);
the TAU Applied Sciences
Award (2009); and the Excellent
Young Scientist Award of the
Israeli Chemistry Society
(2013). Professor Patolsky has
published over 70 papers and
has more than 20 registered
patents to his name.
OTCQB:TECR

RETHINK WELLNESS
THANK YOU

APPENDIX

INTELLECTUAL PROPERTY
PATENTS
Mechanism of using vapors
inside a hat for lice treatment
(provisional 60878351)
Mechanism of using vapors
inside a hat for lice treatment
(PCT/IL2008/000031)
US Pat. 2009/0235949
Registration 04/01/2007 Registration 06/01/2008 Registration 27/05/2009
PCT US 12/901,544
EP 11182376.1
EP 2 438 830 A1
US 13/544,269
Registration 16/06/2009 Registration 10/10/2010 Registration 16/07/2014 Registration 09/07/2012
OTCQB:TECR